The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, H.-U.
Right arrow Articles by Levi-Schaffer, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, H.-U.
Right arrow Articles by Levi-Schaffer, F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
The Journal of Immunology, 2000, 165: 4069-4075.
Copyright © 2000 by The American Association of Immunologists

Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist1

Hans-Uwe Simon2,*, Martina Weber*, Eva Becker{dagger}, Yael Zilberman{ddagger}, Kurt Blaser* and Francesca Levi-Schaffer3,{ddagger}

* Swiss Institute of Allergy and Asthma Research, University of Zurich, {dagger} Clinic for Dermatology and Allergy (Alexanderhausklinik), Davos, Switzerland; and {ddagger} Department of Pharmacology, School of Pharmacy, The Hebrew University-Hadassah Medical School, Jerusalem, Israel

Eosinophils contain in their granules eosinophil cationic protein (ECP) and other basic proteins that have been implicated in immunity to parasites and pathophysiology of chronic allergic responses. In a model of eosinophil degranulation, we show that eosinophils release ECP upon short-term GM-CSF priming and stimulation with either platelet-activating factor (PAF) or the anaphylatoxin C5a, but not eotaxin. Restimulation with the same agonist (PAF or C5a) was unsuccessful as assessed by monitoring intracellular calcium concentration and ECP release. In contrast, upon an intermediate washing step, eosinophils rapidly transduced PAF and C5a signals followed by significant ECP releases. Ligand-binding studies demonstrated that only a proportion of PAF receptors is internalized upon cell stimulation and that washing of the cells removes the agonist from the cell surface. Upon repetitive stimulation, eosinophils with less than 50% of the original ECP content were obtained. Such eosinophils did not increase cellular ECP levels even in the presence of the eosinophil survival factor GM-CSF in overnight cultures. In vivo studies revealed that eosinophils always express detectable amounts of ECP under chronic inflammatory conditions. In conclusion, we have shown that eosinophils maintain their capacity to degranulate upon repetitive stimulation with the same agonist as long as the receptor is not occupied from a previous stimulation. The cellular content of ECP appears to be a no limiting factor in the case of repetitive stimulation, implying that mature eosinophils may not require a significant ECP resynthesis.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
J. Monteseirin, A. Vega, P. Chacon, M. J. Camacho, R. El Bekay, J. A. Asturias, A. Martinez, P. Guardia, R. Perez-Cano, and J. Conde
Neutrophils as a Novel Source of Eosinophil Cationic Protein in IgE-Mediated Processes
J. Immunol., August 15, 2007; 179(4): 2634 - 2641.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Munitz, I. Bachelet, R. Eliashar, A. Moretta, L. Moretta, and F. Levi-Schaffer
The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils
Blood, March 1, 2006; 107(5): 1996 - 2003.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. Altznauer, S. Martinelli, S. Yousefi, C. Thurig, I. Schmid, E. M. Conway, M. H. Schoni, P. Vogt, C. Mueller, M. F. Fey, et al.
Inflammation-associated Cell Cycle-independent Block of Apoptosis by Survivin in Terminally Differentiated Neutrophils
J. Exp. Med., May 17, 2004; 199(10): 1343 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Feistritzer, N. C. Kaneider, D. H. Sturn, B. A. Mosheimer, C. M. Kahler, and C. J. Wiedermann
Expression and Function of the Vascular Endothelial Growth Factor Receptor FLT-1 in Human Eosinophils
Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 729 - 735.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Schmid-Grendelmeier, F. Altznauer, B. Fischer, C. Bizer, A. Straumann, G. Menz, K. Blaser, B. Wuthrich, and H.-U. Simon
Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases
J. Immunol., July 15, 2002; 169(2): 1021 - 1027.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Burke-Gaffney, K. Blease, A. Hartnell, and P. G. Hellewell
TNF-{alpha} Potentiates C5a-Stimulated Eosinophil Adhesion to Human Bronchial Epithelial Cells: A Role for {alpha}5{beta}1 Integrin
J. Immunol., February 1, 2002; 168(3): 1380 - 1388.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. Bandeira-Melo, A. Herbst, and P. F. Weller
Eotaxins . Contributing to the Diversity of Eosinophil Recruitment and Activation
Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 653 - 657.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.